Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
Corporate Governance - Annual Report 2020 | Zur Rose Group AG
Zur Rose Group AG
Zur Rose Aerzte AG Share Price CHF5.75
ZUR ROSE GROUP AG : Shareholders Board Members Managers and Company Profile | CH0042615283 | MarketScreener
Zur Rose Group AG
Downloads - Annual Report 2018 | Zur Rose Group AG
UBS: 1Q21 Net Profit of USD 1.8bn, 18.2% Return on CET1 Capital | Business Wire
Investor Relations | Schindler Group
Corporate Governance
Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland
Goldman Sachs 2020 Annual Report
Zur Rose Group – Marke
Christoph Herrmann – Head of Investor Relations – Zur Rose Group | LinkedIn
EQS-News: Zur Rose Group AG: Aktionäre stimmen allen Anträgen zu
Financials - Annual Report 2020 | Zur Rose Group AG
Olaf Heinrich, Head Germany, verlässt die Zur Rose-Gruppe; sein Nachfolger wird Walter Hess, Head Switzerland
Our 2020 in review | UBS Global
Zur Rose Group AG - Crunchbase Company Profile & Funding
Financial News | Beiersdorf
Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
Zur Rose - News und Aktienkurs | Finanz und Wirtschaft
